ERBASAN, F. Et Al. 2024. Efficacy of disease-modifying antirheumatic drugs in primary Sjögren's syndrome-related interstitial lung disease.. Medicina clinica .

ERBASAN, F., Öğüt, T. S., Dilbil, M., NOKAY, M., TERZİOĞLU, M. E., & YAZISIZ, V., (2024). Efficacy of disease-modifying antirheumatic drugs in primary Sjögren's syndrome-related interstitial lung disease.. Medicina clinica .

ERBASAN, FUNDA Et Al. "Efficacy of disease-modifying antirheumatic drugs in primary Sjögren's syndrome-related interstitial lung disease.," Medicina clinica , 2024

ERBASAN, FUNDA Et Al. "Efficacy of disease-modifying antirheumatic drugs in primary Sjögren's syndrome-related interstitial lung disease.." Medicina clinica , 2024

ERBASAN, F. Et Al. (2024) . "Efficacy of disease-modifying antirheumatic drugs in primary Sjögren's syndrome-related interstitial lung disease.." Medicina clinica .

@article{article, author={FUNDA ERBASAN Et Al. }, title={Efficacy of disease-modifying antirheumatic drugs in primary Sjögren's syndrome-related interstitial lung disease.}, journal={Medicina clinica}, year=2024}